New Directions in Influenza Management

LEARNING OBJECTIVES
Upon proper completion of this activity, participants should be better able to:
• Identify appropriate candidates for antiviral therapy based on risk for influenza-related complications, in accordance with current guideline recommendations
• Determine the need for influenza treatment based on patient signs, symptoms, and accurate interpretation of appropriate diagnostic tests when necessary
• Recommend individualized antiviral treatment plans for patients with, or at risk for, influenza in accordance with the latest evidence

ACCREDITATION AND DESIGNATION STATEMENT
This CE activity is jointly provided by ProCE, Inc and Paradigm Medical Communications, LLC. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-243-L01-P has been assigned to this live knowledge-based CE activity. This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Completion of the evaluation and the posttest are required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.